First human tests begin for new Immune-Targeting drug
Knowledge-focused
Ongoing
This is a very early safety study testing a new drug called budoprutug in healthy volunteers. Researchers will give single injections to 38 healthy adults to see how safe the drug is and how the body processes it. The main goal is to understand side effects and determine appropri…
Phase: EARLY_PHASE1 • Sponsor: Climb Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC